ES394319A1 - Procedimiento de obtencion de composiciones para reducir elnivel de colesterina y lipidos en la sangre. - Google Patents
Procedimiento de obtencion de composiciones para reducir elnivel de colesterina y lipidos en la sangre.Info
- Publication number
- ES394319A1 ES394319A1 ES394319A ES394319A ES394319A1 ES 394319 A1 ES394319 A1 ES 394319A1 ES 394319 A ES394319 A ES 394319A ES 394319 A ES394319 A ES 394319A ES 394319 A1 ES394319 A1 ES 394319A1
- Authority
- ES
- Spain
- Prior art keywords
- triiodothyronine
- thyroxine
- compositions
- hypertriglyceridemias
- hypercholesterolemias
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- AUYYCJSJGJYCDS-UHFFFAOYSA-N 2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid Chemical compound IC1=CC(CC(N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-UHFFFAOYSA-N 0.000 title abstract 2
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 208000006575 hypertriglyceridemia Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Procedimiento de obtención de composiciones para reducir el nivel de colesterina y lípidos en la sangre, caracterizado porque comprende mezclar, bajo efectos sinergísticos, d-tiroxina, o una de sus sales fisiológicamente compatibles, y d-triyodotironina, o una de sus sales fisiológicamente compatibles, en una proporción en peso de 1:1 a 10:1; y combinar el producto resultante con un adyuvante o excipiente sólido, líquido o semisólido.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19712126533 DE2126533A1 (de) | 1971-05-28 | 1971-05-28 | Verfahren zur Herstellung pharma zeutischer Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES394319A1 true ES394319A1 (es) | 1975-04-01 |
Family
ID=5809169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES394319A Expired ES394319A1 (es) | 1971-05-28 | 1971-08-18 | Procedimiento de obtencion de composiciones para reducir elnivel de colesterina y lipidos en la sangre. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3917832A (es) |
| AT (1) | AT306228B (es) |
| AU (1) | AU3450471A (es) |
| BE (1) | BE773121A (es) |
| BR (1) | BR7105898D0 (es) |
| DE (1) | DE2126533A1 (es) |
| ES (1) | ES394319A1 (es) |
| FR (1) | FR2139787B1 (es) |
| GB (1) | GB1296510A (es) |
| HU (1) | HU162454B (es) |
| IL (1) | IL37640A (es) |
| NL (1) | NL7111198A (es) |
| ZA (1) | ZA715734B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9401879D0 (en) * | 1994-02-01 | 1994-03-30 | Boots Co Plc | Therapeutic agents |
| GB9401892D0 (en) * | 1994-02-01 | 1994-03-30 | Boots Co Plc | Therapeutic agents |
| GB9401891D0 (en) | 1994-02-01 | 1994-03-30 | Boots Co Plc | Therapeutic agents |
| DE19821625C1 (de) | 1998-05-15 | 2000-01-05 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
| US20040152783A1 (en) * | 2002-11-05 | 2004-08-05 | Olon Lawrence Peter | Controlled absorption of admixed thyroid hormone formulations |
| EP2148660A2 (en) * | 2007-04-23 | 2010-02-03 | Diurnal Ltd | Sustained release |
| EP2429992A4 (en) * | 2009-05-15 | 2012-11-28 | Univ Kentucky Res Found | TREATMENT OF EASY COGNITIVE IMMUNITY AND MORBUS ALZHEIMER |
| US9968574B2 (en) * | 2009-05-15 | 2018-05-15 | The University Of Kentucky Research Foundation | Treatment of MCI and Alzheimer's disease |
| WO2011142778A1 (en) * | 2010-05-13 | 2011-11-17 | The University Of Kentucky Research Foundation | Treatment of mci and alzheimer's disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2925364A (en) * | 1957-08-12 | 1960-02-16 | Baxter Laboratories Inc | Method of treating hypercholesterol-emia with d-thyroxine |
| US3157574A (en) * | 1959-05-01 | 1964-11-17 | Smith Kline French Lab | Method of reducing cholesterol levels |
-
1971
- 1971-05-28 DE DE19712126533 patent/DE2126533A1/de active Pending
- 1971-08-02 AT AT674171A patent/AT306228B/de not_active IP Right Cessation
- 1971-08-13 NL NL7111198A patent/NL7111198A/xx unknown
- 1971-08-18 ES ES394319A patent/ES394319A1/es not_active Expired
- 1971-08-27 ZA ZA715734A patent/ZA715734B/xx unknown
- 1971-09-02 IL IL37640A patent/IL37640A/en unknown
- 1971-09-08 BR BR5898/71A patent/BR7105898D0/pt unknown
- 1971-09-14 HU HUME1420A patent/HU162454B/hu unknown
- 1971-09-17 GB GB1296510D patent/GB1296510A/en not_active Expired
- 1971-09-21 FR FR7133894A patent/FR2139787B1/fr not_active Expired
- 1971-09-24 US US183663A patent/US3917832A/en not_active Expired - Lifetime
- 1971-09-27 BE BE773121A patent/BE773121A/xx unknown
- 1971-10-13 AU AU34504/71A patent/AU3450471A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2126533A1 (de) | 1972-12-14 |
| BR7105898D0 (pt) | 1973-05-10 |
| US3917832A (en) | 1975-11-04 |
| IL37640A (en) | 1974-10-22 |
| FR2139787A1 (es) | 1973-01-12 |
| BE773121A (fr) | 1972-03-27 |
| ZA715734B (en) | 1973-04-25 |
| HU162454B (es) | 1973-02-28 |
| AT306228B (de) | 1973-03-26 |
| AU3450471A (en) | 1973-04-19 |
| FR2139787B1 (es) | 1974-09-06 |
| NL7111198A (es) | 1972-11-30 |
| GB1296510A (es) | 1972-11-15 |
| IL37640A0 (en) | 1971-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL38687A (en) | Omega-imidazolyl-omega-phenoxy-alkanones,their preparation and pharmaceutical compositions containing them | |
| IL40184A0 (en) | 5-cinnamoyl-benzofurans,their preparation and pharmaceutical compositions containing them | |
| IL39694A0 (en) | The use of certain pyrazolylbenzimidazoles as fungicides and bactericides | |
| IL39110A (en) | Sulphamides,their preparation and pharmaceutical compositions containing them | |
| IE35991L (en) | Camphor-containing pharmaceutical composition | |
| ES394319A1 (es) | Procedimiento de obtencion de composiciones para reducir elnivel de colesterina y lipidos en la sangre. | |
| JPS5293767A (en) | Novel oxazolidone derivatives and preparation thereof | |
| IL40572A0 (en) | Biphenylyl-butanols,their preparation and pharmaceutical compositions containing them | |
| IL48790A0 (en) | Novel hydroxy-pyrimidines,their preparation and pharmaceutical compositions containing them | |
| ZA722077B (en) | Veterinary and pharmaceutical compositions | |
| CA1005273A (en) | Photographic products, processes and compositions | |
| PH11404A (en) | 2(n-substituted-phenylamino)-imidazolines-(2)and pharmaceutical compositions thereof | |
| GB1370904A (en) | Pharmaceutical composition | |
| AU4775772A (en) | Compositions and processes | |
| IE36289B1 (en) | 2,4 - diamino-5-benzylpyrimidines and preparations thereof | |
| GB1372721A (en) | Containers of antiseptics for the treatment of burns and scalds | |
| IL40194A (en) | 2-acetyl(or propionyl)-8-chloro-10-(2-methyl-3-dimethylaminopropyl)-phenothiazines,processes for their preparation and pharmaceutical compositions containing the same | |
| AU4191572A (en) | Improvements in or relating tothe processing of calcium carbonates | |
| ZA721937B (en) | Pharmaceutical preparations and uses thereof | |
| CA947528A (en) | Manure processing and improved treatment materials | |
| ZA729148B (en) | Thiazolotriazolyphosphonothioates,preparation and uses thereof | |
| AU4453472A (en) | Self-shining treatment substances | |
| IL41373A (en) | Alpha-d-4-dimethylamino-3-methyl-1,2-diphenyl-2-propionyloxybutane theobromineacetate,its preparation and pharmaceutical compositions containing it | |
| KE2621A (en) | Pharmaceutical preparation and treatment | |
| ZA721486B (en) | Zirconium flame-resist treatment |